Wang, K., Li, Z., Xuan, Y., Zhao, Y., Deng, C., Wang, M., . . . Mei, J. (2023). Pan-cancer analysis of NFE2L2 mutations identifies a subset of lung cancers with distinct genomic and improved immunotherapy outcomes. BMC.
शिकागो शैली (17वां संस्करण) प्रशस्ति पत्रWang, Kewei, et al. Pan-cancer Analysis of NFE2L2 Mutations Identifies a Subset of Lung Cancers with Distinct Genomic and Improved Immunotherapy Outcomes. BMC, 2023.
एमएलए (9वां संस्करण) प्रशस्ति पत्रWang, Kewei, et al. Pan-cancer Analysis of NFE2L2 Mutations Identifies a Subset of Lung Cancers with Distinct Genomic and Improved Immunotherapy Outcomes. BMC, 2023.
चेतावनी: ये उद्धरण हमेशा 100% सटीक नहीं हो सकते हैं.